Collegium Pharmaceutical (COLL) Cash from Operations (2014 - 2026)

Collegium Pharmaceutical's Cash from Operations history runs 13 years deep, the most recent figure standing at 57113000.0 for Q1 2026.

• On a quarterly basis, Cash from Operations rose 3.1% year-over-year to 57113000.0 in Q1 2026; TTM through Mar 2026 was 331038000.0, a 66.82% increase from a year earlier, with the FY2025 full-year figure at 329323000.0, up 60.66% from the prior year.
• Cash from Operations declined to 57113000.0 in Q1 2026 per COLL's latest filing, from 123048000.0 in the prior quarter.
• Across five years, Cash from Operations topped out at 123048000.0 in Q4 2025 and bottomed at 25315000.0 in Q1 2022.
• The 5-year median for Cash from Operations is 66325000.0 (2022), against an average of 58258529.41.
• Across the five-year window, Cash from Operations slumped 223.07% in 2022 and soared 971.63% in 2025, its largest moves.
• Year by year, Cash from Operations stood at 66325000.0 in 2022, then climbed by 10.57% to 73338000.0 in 2023, then gained by 15.42% to 84644000.0 in 2024, then jumped by 45.37% to 123048000.0 in 2025, then slumped by 53.58% to 57113000.0 in 2026.
• Per Business Quant, the three latest COLL Cash from Operations figures stand at 57113000.0 (Q1 2026), 123048000.0 (Q4 2025), and 78438000.0 (Q3 2025).